Watch Ticker

Vanda Pharmaceuticals Inc.

Go to Vanda Pharmaceuticals Inc. Website

$4.17

-0.09 (-2.11%)

Live

Previous Close

$4.26

Day Range

$4.1701 - $4.28

Previous Day Range

$4.15 - $4.275

Market Cap

$247.6 million USD

Day Vol.

366677

Previous Day Vol.

598658

Currency

USD

Primary Exchange

Nasdaq

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ f...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Jesterai - Vanda (VNDA) Q2 Revenue Rises 4%

Vanda Pharmaceuticals reported a Q2 2025 net loss of $27.2 million, with revenue rising 4% to $52.6 million. Fanapt® showed strong sales growth, while HETLIOZ® and PONVORY® experienced declines. The company continues to invest in its product pipeline and expand market reach.

Related tickers: VNDA.

Read Full Article

Delveinsight - Schizophrenia Clinical Trial Pipeline Insights Featuring 55+ Companies | DelveInsight

The schizophrenia market is growing due to increased R&D activities, advancements in neurobiology and biomarkers, and ongoing clinical trials for more effective treatments. This has attracted significant investments and led to the development of innovative therapies, including novel antipsychotics and personalized medicine.

Related tickers: RVPH, RVPHW, VNDA, LYPHF.

Read Full Article

Trending Tickers

Please sign in to view